147 related articles for article (PubMed ID: 14654105)
1. Identification and characterisation of SB-366791, a potent and selective vanilloid receptor (VR1/TRPV1) antagonist.
Gunthorpe MJ; Rami HK; Jerman JC; Smart D; Gill CH; Soffin EM; Luis Hannan S; Lappin SC; Egerton J; Smith GD; Worby A; Howett L; Owen D; Nasir S; Davies CH; Thompson M; Wyman PA; Randall AD; Davis JB
Neuropharmacology; 2004 Jan; 46(1):133-49. PubMed ID: 14654105
[TBL] [Abstract][Full Text] [Related]
2. Gingerols: a novel class of vanilloid receptor (VR1) agonists.
Dedov VN; Tran VH; Duke CC; Connor M; Christie MJ; Mandadi S; Roufogalis BD
Br J Pharmacol; 2002 Nov; 137(6):793-8. PubMed ID: 12411409
[TBL] [Abstract][Full Text] [Related]
3. Characterization using FLIPR of rat vanilloid receptor (rVR1) pharmacology.
Jerman JC; Brough SJ; Prinjha R; Harries MH; Davis JB; Smart D
Br J Pharmacol; 2000 Jun; 130(4):916-22. PubMed ID: 10864900
[TBL] [Abstract][Full Text] [Related]
4. A Stable Cell Line Co-expressing hTRPV1 and GCaMP6s: A Novel Cell-based Assay For High-throughput Screening of hTRPV1 Agonists.
Shi J; Chen X; Zhang Y; Shi T; Zhang R; Zhu S; Zong X; Wang C; Li L
Comb Chem High Throughput Screen; 2024; 27(2):298-306. PubMed ID: 37171000
[TBL] [Abstract][Full Text] [Related]
5. Capsaicinoids cause inflammation and epithelial cell death through activation of vanilloid receptors.
Reilly CA; Taylor JL; Lanza DL; Carr BA; Crouch DJ; Yost GS
Toxicol Sci; 2003 May; 73(1):170-81. PubMed ID: 12721390
[TBL] [Abstract][Full Text] [Related]
6. Effective suppression of I
Wong SL; Shih CL; Cho HY; Wu SN
Brain Res; 2024 Sep; 1839():149008. PubMed ID: 38761846
[TBL] [Abstract][Full Text] [Related]
7. The ion channel TRPV1 regulates the activation and proinflammatory properties of CD4⁺ T cells.
Bertin S; Aoki-Nonaka Y; de Jong PR; Nohara LL; Xu H; Stanwood SR; Srikanth S; Lee J; To K; Abramson L; Yu T; Han T; Touma R; Li X; González-Navajas JM; Herdman S; Corr M; Fu G; Dong H; Gwack Y; Franco A; Jefferies WA; Raz E
Nat Immunol; 2014 Nov; 15(11):1055-1063. PubMed ID: 25282159
[TBL] [Abstract][Full Text] [Related]
8. Discovery of N-(1,4-Benzoxazin-3-one) urea analogs as Mode-Selective TRPV1 antagonists.
Huang G; Jung A; Li LX; Do N; Jung S; Jeon Y; Zuo D; Thanh La M; Van Manh N; Blumberg PM; Yoon H; Lee Y; Ann J; Lee J
Bioorg Med Chem Lett; 2024 Jul; 106():129735. PubMed ID: 38588785
[TBL] [Abstract][Full Text] [Related]
9. Sens-ocular model: Cell-based assay to evaluate eye stinging potential of chemicals and baby cosmetic formulations.
Brito LB; Catarino CM; Passos MC; Garcia Silva AC; Schuck DC; Canavez ADPM; Valadares MC
Toxicol In Vitro; 2024 Jun; 98():105824. PubMed ID: 38614139
[TBL] [Abstract][Full Text] [Related]
10. Antioxidative and Analgesic Effects of Naringin through Selective Inhibition of Transient Receptor Potential Vanilloid Member 1.
Eom S; Lee BB; Lee S; Park Y; Yeom HD; Kim TH; Nam SH; Lee JH
Antioxidants (Basel); 2021 Dec; 11(1):. PubMed ID: 35052566
[TBL] [Abstract][Full Text] [Related]
11. Effects of capsaicin on human intestinal cell line Caco-2.
Isoda H; Han J; Tominaga M; Maekawa T
Cytotechnology; 2001 Jul; 36(1-3):155-61. PubMed ID: 19003326
[TBL] [Abstract][Full Text] [Related]
12. A molecular perspective on identifying TRPV1 thermosensitive regions and disentangling polymodal activation.
Luu DD; Owens AM; Mebrat MD; Van Horn WD
Temperature (Austin); 2023; 10(1):67-101. PubMed ID: 37187836
[TBL] [Abstract][Full Text] [Related]
13. Elusive equilibrium: the challenge of interpreting receptor pharmacology using calcium assays.
Charlton SJ; Vauquelin G
Br J Pharmacol; 2010 Nov; 161(6):1250-65. PubMed ID: 20977466
[TBL] [Abstract][Full Text] [Related]
14. Repeated doses of captopril induce airway hyperresponsiveness by modulating the TRPV1 receptor in rats.
de Oliveira JRJM; Amorim MA; Oliveira VHS; Cabrini DA; Otuki MF; Galindo CM; da Luz BB; Werner MFP; Calixto JB; André E
Pulm Pharmacol Ther; 2024 May; 86():102302. PubMed ID: 38823475
[TBL] [Abstract][Full Text] [Related]
15. Thermo-ring basis for heat unfolding-induced inactivation in TRPV1.
Wang G
Res Sq; 2024 May; ():. PubMed ID: 37674717
[TBL] [Abstract][Full Text] [Related]
16. Integrated virtual screening and
Song L; Mi S; Zhao Y; Liu Z; Wang J; Wang H; Li W; Wang J; Zu W; Du H
Front Pharmacol; 2024; 15():1367682. PubMed ID: 38500766
[No Abstract] [Full Text] [Related]
17. Structural Basis of the Bivalency of the TRPV1 Agonist DkTx.
Ramanujam V; Crawford T; Cristofori-Armstrong B; Deuis JR; Jia X; Maxwell MJ; Jami S; Ma L; Vetter I; Mobli M
Angew Chem Int Ed Engl; 2024 Jan; 63(3):e202314621. PubMed ID: 37953402
[TBL] [Abstract][Full Text] [Related]
18. Evolutionary biology at BGRS\SB-2016.
Baranova AV; Orlov YL
BMC Evol Biol; 2017 Feb; 17(Suppl 1):21. PubMed ID: 28251876
[No Abstract] [Full Text] [Related]
19. The vanilloid receptor TRPV1: 10 years from channel cloning to antagonist proof-of-concept.
Szallasi A; Cortright DN; Blum CA; Eid SR
Nat Rev Drug Discov; 2007 May; 6(5):357-72. PubMed ID: 17464295
[TBL] [Abstract][Full Text] [Related]
20. Effects of the novel TRPV1 receptor antagonist SB366791 in vitro and in vivo in the rat.
Varga A; Németh J; Szabó A; McDougall JJ; Zhang C; Elekes K; Pintér E; Szolcsányi J; Helyes Z
Neurosci Lett; 2005 Sep; 385(2):137-42. PubMed ID: 15950380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
